VR Adviser, LLC
- SEC CIK
- 0001615982
2026 年第 2 季 持倉
持倉截至 2026/6/30，申報日 2026/8/14。SEC
- 持股檔數
- 33
- 較 2026 年第 1 季 0
- 總值
- $32.98 億
- 較 2026 年第 1 季 +$6.19 億 (+23.1%)
持股
只含多頭部位。變化是跟 2026 年第 1 季 比股數。
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 歷年 |
|---|---|---|---|---|---|---|---|
| APOGEE THERAPEUTICS INC03770N101 | COM | 8,493,321 | $11.27 億 | 34.18% | 00.0% | 不變 | – |
| ORKAORUKA THERAPEUTICS INC | COM | 4,148,428 | $3.95 億 | 11.97% | 00.0% | 不變 | 查看 |
| ERASERASCA INC | COM | 17,891,812 | $3.28 億 | 9.94% | +1,509,000+9.2% | 加碼 | 查看 |
| SYRESPYRE THERAPEUTICS INC | COM NEW | 2,985,448 | $2.65 億 | 8.04% | −700,000−19.0% | 減碼 | 查看 |
| DNTHDIANTHUS THERAPEUTICS INC | COM | 1,180,000 | $1.15 億 | 3.49% | 00.0% | 不變 | 查看 |
| OCULOCULAR THERAPEUTIX INC | COM | 10,346,926 | $1.02 億 | 3.08% | 00.0% | 不變 | 查看 |
| DMRADAMORA THERAPEUTICS INC | COM NEW | 3,603,595 | $9,372.95 萬 | 2.84% | 00.0% | 不變 | 查看 |
| SVRASAVARA INC | COM | 14,745,943 | $9,083.5 萬 | 2.75% | +1,005,568+7.3% | 加碼 | 查看 |
| JBIOJADE BIOSCIENCES INC | COM NEW | 3,220,364 | $7,155.65 萬 | 2.17% | 00.0% | 不變 | 查看 |
| COGTCOGENT BIOSCIENCES INC | COM | 1,642,166 | $6,355.18 萬 | 1.93% | −357,834−17.9% | 減碼 | 查看 |
| VRDNVIRIDIAN THERAPEUTICS INC | COM | 3,257,917 | $5,984.79 萬 | 1.81% | −624,792−16.1% | 減碼 | 查看 |
| VORVOR BIOPHARMA INC | COM NEW | 3,041,719 | $5,599.8 萬 | 1.70% | 00.0% | 不變 | 查看 |
| DYNDYNE THERAPEUTICS INC | COM | 2,173,913 | $4,828.26 萬 | 1.46% | 00.0% | 不變 | 查看 |
| MAZEMAZE THERAPEUTICS INC | COM | 1,602,034 | $4,780.47 萬 | 1.45% | 00.0% | 不變 | 查看 |
| RLMDRELMADA THERAPEUTICS INC | COM | 6,844,305 | $4,736.26 萬 | 1.44% | +2,000,925+41.3% | 加碼 | 查看 |
| ORICORIC PHARMACEUTICALS INC | COM | 4,319,765 | $4,678.31 萬 | 1.42% | 00.0% | 不變 | 查看 |
| CBIOCRESCENT BIOPHARMA INC. | COM | 2,133,576 | $3,840.44 萬 | 1.16% | 00.0% | 不變 | 查看 |
| ZURAZURA BIO LTD | CLASS A ORD SHS | 6,434,990 | $3,796.64 萬 | 1.15% | 00.0% | 不變 | 查看 |
| ANLADLAI NORTYE LTD | ADS | 3,212,731 | $3,694.64 萬 | 1.12% | 00.0% | 不變 | 查看 |
| ELVNENLIVEN THERAPEUTICS INC | COM | 526,331 | $2,671.13 萬 | 0.81% | −1,200,000−69.5% | 減碼 | 查看 |
| HELPCYBIN INC | COM NEW | 3,851,654 | $2,545.94 萬 | 0.77% | 00.0% | 不變 | 查看 |
| CGEMCULLINAN THERAPEUTICS INC | COM | 1,379,965 | $2,512.92 萬 | 0.76% | 00.0% | 不變 | 查看 |
| IPSCCENTURY THERAPEUTICS INC | COM | 8,695,652 | $2,130.43 萬 | 0.65% | 00.0% | 不變 | 查看 |
| ARTVARTIVA BIOTHERAPEUTICS INC | COM | 2,043,596 | $1,982.29 萬 | 0.60% | +434,027+27.0% | 加碼 | 查看 |
| CTMXCYTOMX THERAPEUTICS INC. | COM | 4,982,124 | $1,868.3 萬 | 0.57% | −5,000,000−50.1% | 減碼 | 查看 |
| ACHVACHIEVE LIFE SCIENCE INC | COM | 2,751,032 | $1,796.42 萬 | 0.54% | +2,751,032 | 新進 | 查看 |
| PBLSPARABILIS MEDICINES INC COM | Stock | 625,000 | $1,710.63 萬 | 0.52% | +625,000 | 新進 | 查看 |
| SRZNSURROZEN INC | COM NEW | 632,931 | $1,642.46 萬 | 0.50% | 00.0% | 不變 | 查看 |
| KRROKORRO BIO INC | COM | 1,009,500 | $1,330.52 萬 | 0.40% | 00.0% | 不變 | 查看 |
| ANROALTO NEUROSCIENCE INC | COM SHS | 500,000 | $1,319.5 萬 | 0.40% | 00.0% | 不變 | 查看 |
| XFORX4 PHARMACEUTICALS INC | COM NEW | 1,934,253 | $903.3 萬 | 0.27% | +1,603,728+485.2% | 加碼 | 查看 |
| RACCRESEARCH ALLIANCE CORP III | ORD SHS CL A | 300,000 | $321 萬 | 0.10% | +300,000 | 新進 | 查看 |
| INMINMED PHARMACEUTICALS INC | Common Stock | 32,685 | $5.07 萬 | 0.00% | +32,685 | 新進 | 查看 |
2026 年第 1 季 之後清倉（4 檔）
2026 年第 1 季 季末還持有、這份申報已經沒有的部位。